{"id":"W3087889571","doi":"10.1016/j.molmet.2020.101090","title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","year":2020,"lang":"en","type":"review","venue":"Molecular Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden","keywords":"Amylin; Medicine; Exenatide; Semaglutide; Liraglutide; Agonist; Type 2 diabetes; Glycemic; Glucagon-like peptide 1 receptor; Weight loss; Steatohepatitis; Bioinformatics; Diabetes mellitus; Pharmacology; Disease; Internal medicine; Endocrinology; Receptor; Obesity; Biology; Fatty liver; Islet","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004302186,0.0004823872,0.0005930823,0.0007013378,0.0001068746,0.0006158495,0.0003615771,0.0006294727,0.004261874],"category_scores_gemma":[0.0004395959,0.00008628044,0.0004513267,0.000439059,0.0002122078,0.0005161736,0.0004009868,0.001414571,0.002055949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000318196,"about_ca_system_score_gemma":0.0004623944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002443595,"about_ca_topic_score_gemma":0.0004510917,"domain_scores_codex":[0.999832,0.00004314831,0.00001970296,0.00002701837,0.00005872665,0.00001932802],"domain_scores_gemma":[0.9998249,0.00006759199,0.00004442521,0.000005797348,0.00003950966,0.00001779821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000237502,0.00009651003,0.0001731261,0.01400406,0.0001607342,0.0002331772,0.00004605591,0.0003733955,0.009748451,0.005946937,0.03495334,0.9340267],"study_design_scores_gemma":[0.00008196609,0.0003272602,0.0008175375,0.003800272,0.0002122273,0.001231816,0.00004457031,0.0001885753,0.002748388,0.002714089,0.9878141,0.00001919495],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004915084,0.9947662,0.0004651141,0.000943172,0.0006813917,0.00001774833,0.00004897944,0.00002755272,0.002558266],"genre_scores_gemma":[0.004532692,0.9913529,0.0006102129,0.0007942811,0.0007737369,0.00002720877,0.00007852774,0.000006423986,0.001824079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004261874,"threshold_uncertainty_score":0.01425743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02732589598191354,"score_gpt":0.3265732227397154,"score_spread":0.2992473267578019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}